Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read MoreMerck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreCNBC's Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them
Read MoreThese are the stocks posting the largest moves in extended trading. Source link
Read MoreShares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday. Source link
Read MoreStarboard's Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as "flagrantly
Read MoreThe about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was
Read MoreThese are the stocks posting the largest moves in premarket trading. Source link
Read MoreStarboard's stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand
Read More